656 related articles for article (PubMed ID: 10493110)
1. Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurons.
Bleakman D; Ogden AM; Ornstein PL; Hoo K
Eur J Pharmacol; 1999 Aug; 378(3):331-7. PubMed ID: 10493110
[TBL] [Abstract][Full Text] [Related]
2. LY339434, a GluR5 kainate receptor agonist.
Small B; Thomas J; Kemp M; Hoo K; Ballyk B; Deverill M; Ogden AM; Rubio A; Pedregal C; Bleakman D
Neuropharmacology; 1998; 37(10-11):1261-7. PubMed ID: 9849663
[TBL] [Abstract][Full Text] [Related]
3. Comparative patch clamp studies on the kinetics and selectivity of glutamate receptor antagonism by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline (NBQX) and 1-(4-amino-phenyl)-4-methyl-7,8-methyl-endioxyl-5H-2,3-benzodiaze pine (GYKI 52466).
Parsons CG; Gruner R; Rozental J
Neuropharmacology; 1994 May; 33(5):589-604. PubMed ID: 7523977
[TBL] [Abstract][Full Text] [Related]
4. Activation and desensitization of hippocampal kainate receptors.
Wilding TJ; Huettner JE
J Neurosci; 1997 Apr; 17(8):2713-21. PubMed ID: 9092592
[TBL] [Abstract][Full Text] [Related]
5. Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA.
Stensbøl TB; Borre L; Johansen TN; Egebjerg J; Madsen U; Ebert B; Krogsgaard-Larsen P
Eur J Pharmacol; 1999 Sep; 380(2-3):153-62. PubMed ID: 10513575
[TBL] [Abstract][Full Text] [Related]
6. (2S,4R)-4-methylglutamic acid (SYM 2081): a selective, high-affinity ligand for kainate receptors.
Zhou LM; Gu ZQ; Costa AM; Yamada KA; Mansson PE; Giordano T; Skolnick P; Jones KA
J Pharmacol Exp Ther; 1997 Jan; 280(1):422-7. PubMed ID: 8996224
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of kainate receptor mediated whole-cell currents in rat cultured cerebellar granule cells.
Savidge JR; Sturgess NC; Bristow DR; Lock EA
Neuropharmacology; 1999 Mar; 38(3):375-82. PubMed ID: 10219975
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y release from cultured hippocampal neurons: stimulation by glutamate acting at N-methyl-D-aspartate and AMPA receptors.
Gemignani A; Marchese S; Fontana G; Raiteri M
Neuroscience; 1997 Nov; 81(1):23-31. PubMed ID: 9300398
[TBL] [Abstract][Full Text] [Related]
9. Comparative antagonism of kainate-activated kainate and AMPA receptors in hippocampal neurons.
Paternain AV; Vicente A; Nielsen EO; Lerma J
Eur J Neurosci; 1996 Oct; 8(10):2129-36. PubMed ID: 8921304
[TBL] [Abstract][Full Text] [Related]
10. Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.
D'Hooge R; Raes A; Van de Vijver G; Van Bogaert PP; De Deyn PP
Fundam Clin Pharmacol; 1999; 13(1):67-74. PubMed ID: 10027090
[TBL] [Abstract][Full Text] [Related]
11. Regulation of spontaneous inhibitory synaptic transmission by endogenous glutamate via non-NMDA receptors in cultured rat hippocampal neurons.
Vignes M
Neuropharmacology; 2001 May; 40(6):737-48. PubMed ID: 11369028
[TBL] [Abstract][Full Text] [Related]
12. Competitive inhibition by NBQX of kainate/AMPA receptor currents and excitatory synaptic potentials: importance of 6-nitro substitution.
Randle JC; Guet T; Cordi A; Lepagnol JM
Eur J Pharmacol; 1992 May; 215(2-3):237-44. PubMed ID: 1382998
[TBL] [Abstract][Full Text] [Related]
13. Desensitization of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate.
Jones KA; Wilding TJ; Huettner JE; Costa AM
Neuropharmacology; 1997 Jun; 36(6):853-63. PubMed ID: 9225313
[TBL] [Abstract][Full Text] [Related]
14. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles.
Bleakman D; Ballyk BA; Schoepp DD; Palmer AJ; Bath CP; Sharpe EF; Woolley ML; Bufton HR; Kamboj RK; Tarnawa I; Lodge D
Neuropharmacology; 1996; 35(12):1689-702. PubMed ID: 9076748
[TBL] [Abstract][Full Text] [Related]
15. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
[TBL] [Abstract][Full Text] [Related]
16. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons.
Gibbs JW; Sombati S; DeLorenzo RJ; Coulter DA
Epilepsia; 2000; 41(S1):10-6. PubMed ID: 10768293
[TBL] [Abstract][Full Text] [Related]
17. Functional characteristics of non-NMDA-type ionotropic glutamate receptor channels in AII amacrine cells in rat retina.
Mørkve SH; Veruki ML; Hartveit E
J Physiol; 2002 Jul; 542(Pt 1):147-65. PubMed ID: 12096058
[TBL] [Abstract][Full Text] [Related]
18. Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones.
Dinse A; Föhr KJ; Georgieff M; Beyer C; Bulling A; Weigt HU
Br J Anaesth; 2005 Apr; 94(4):479-85. PubMed ID: 15695547
[TBL] [Abstract][Full Text] [Related]
19. Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function.
Pittaluga A; Bonfanti A; Raiteri M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):29-38. PubMed ID: 9228187
[TBL] [Abstract][Full Text] [Related]
20. Development of calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in cultured neocortical neurons visualized by cobalt staining.
Jensen JB; Schousboe A; Pickering DS
J Neurosci Res; 1998 Oct; 54(2):273-81. PubMed ID: 9788286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
